Beschreibung
Cytotoxic T-lymphocyte protein 4, also known as CTLA4 and CD152, is a single-pass type I membrane protein. CTLA4 is a member of the immunoglobulin superfamily, which is expressed on the surface of Helper T cells and it is also found in regulatory T cells. CTLA4 is similar to the T-cell co-stimulatory protein, CD28, and both molecules bind to CD80 and CD86, also called B7-1 and B7-2 respectively, on antigen-presenting cells.
Product Information
|
Product Information. |
Catalog Number |
Size |
|
Recombinant Rat CTLA-4/CD152 Protein,His Tag |
96596ES60 |
100 μg |
|
96596ES76 |
500 μg |
Product Properties
|
Synonyms |
CTLA4,CD152 |
|
Species |
Rat |
|
Expression Sequence |
Ile38-Asp161,with C-terminal His |
|
Accession |
Q62859 |
|
Tag |
C-His Tag |
|
Expression System |
HEK293 |
|
Molecular Weight |
19-26 kDa (Reducing) |
|
Purity |
> 95% as determined by SDS-PAGE. |
|
Endotoxin |
< 0.1 EU/μg |
|
Formulation |
PBS, pH7.4. |
|
Appearance |
Lyophilized Powder |
|
Reconstitution Method |
Reconstitute at 0.1-1 mg/mL according to the size in ultrapure water after rapid centrifugation. |
Product Features
High activity, high purity, low endotoxin, high lot-to-lot consistency
Application Example
ELISA Data: Immobilized CTLA-4/CD152 His Tag Protein, Rat at 2.0 μg/mL (100 μL/well) can bind B7-1/CD80 Fc Chimera Protein, Mouse with EC50 of 1.36-1.57 ng/mL.
Storage
Store at -25 ~ -15°C, valid for 1 year after receipt. After reconstitution, store at 2~8°C under sterile conditions, valid for 7 days. After reconstitution, store at -85 ~ -65°C under sterile conditions, valid for 3 months.
Documents:
Manuals
Zahlung und Sicherheit
Ihre Zahlungsinformationen werden sicher verarbeitet. Wir speichern weder Kreditkartendaten noch Zugriff auf Ihre Kreditkarteninformationen.
Sie können auch mögen
Anfrage
FAQ
Das Produkt ist nur für Forschungszwecke bestimmt und nicht für die therapeutische oder diagnostische Anwendung bei Menschen oder Tieren. Produkte und Inhalte sind durch Patente, Marken und Urheberrechte von
Für bestimmte Anwendungen sind möglicherweise zusätzliche geistige Eigentumsrechte Dritter erforderlich.

